Poseida Therapeutics, Inc.
PSTX
Revenue
25.97M
▼-2.17M▼-7.71%
3 Months ChangeAssets
298.69M
▲36.11M▲13.75%
3 Months ChangeLiabilities
237.87M
▲59.88M▲33.64%
3 Months ChangeFree Cash Flow
-15.27M
▲23.52M▲60.65%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-30
Form 8-K
ID: 0001193125-24-228441
2024-08-05
Form 10-Q
ID: 0000950170-24-090747
2024-08-05
Form 8-K
ID: 0000950170-24-090732
2024-06-18
Form 8-K
ID: 0000950170-24-074860
2024-05-14
Form 10-Q
ID: 0000950170-24-059551
2024-05-14
Form 8-K
ID: 0000950170-24-059522
2024-05-01
Form 8-K
ID: 0001193125-24-126509
2024-04-17
Form 8-K
ID: 0001193125-24-098680
2024-04-08
Form 8-K
ID: 0001193125-24-089653
2024-03-07
Form 8-K
ID: 0000950170-24-027932